Related Experiment Video
Updated: May 29, 2026
12:23
Granulocyte-dependent Autoantibody-induced Skin Blistering
Published on: October 12, 2012
Minimizing complications in autoimmune blistering diseases
1Meharry Medical College, 1829 Morena Street, Apartment B, Nashville, TN 37208, USA.
Dermatologic Clinics
|September 20, 2011
Summary
Managing autoimmune blistering diseases (AIBD) involves controlling symptoms while mitigating side effects from corticosteroids and immunosuppressants. This review details supportive care and managing treatment complications for AIBD patients.
Area of Science:
- Dermatology
- Immunology
- Internal Medicine
Background:
- Autoimmune blistering diseases (AIBD) necessitate potent treatments like high-dose corticosteroids and immunosuppressive agents.
- These conditions lead to substantial patient morbidity, and treatments carry risks of side effects and complications.
Purpose of the Study:
- To review supportive management strategies for AIBD.
- To outline the management of corticosteroid-induced side effects.
- To summarize the prevention and management of secondary effects from common AIBD steroid-sparing agents.
Main Methods:
- Literature review of supportive care in AIBD.
- Analysis of corticosteroid side effect management.
- Summary of adverse event profiles for steroid-sparing agents used in AIBD.
Main Results:
- Effective AIBD management requires balancing disease control with minimizing treatment-related adverse events.
- Supportive care is crucial for managing morbidity associated with AIBD and its treatments.
- Understanding and addressing side effects of both corticosteroids and steroid-sparing agents is essential.
Conclusions:
- Optimal patient care in AIBD demands comprehensive knowledge of supportive management and treatment side effect mitigation.
- Clinicians need to be well-versed in managing complications to ensure patient safety and treatment efficacy.
- Proactive management of side effects improves outcomes for patients with autoimmune blistering diseases.
Related Concept Videos
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
01:27Acne Infection
Acne is a multifactorial skin condition primarily affecting adolescents and young adults, with a global prevalence estimated to exceed 75% in this demographic. The condition is characterized by the formation of comedones (blackheads and whiteheads), papules, pustules, nodules, and, in severe cases, cysts, particularly in areas rich in sebaceous glands such as the face, neck, chest, and back. The pathogenesis involves increased sebum production, follicular hyperkeratinization, colonization by...
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
01:23Skin Diseases and Disorders
Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
01:29Drugs for Treatment of Ulcerative Colitis in IBD
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation.
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...